XTX Markets’s Zosano Pharma Corporation ZSAN Stock Holding History

XTX Markets’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-313	Closed	-$17K	–	150
2019 Q4	$17K	Buy	+313	New	+$19.3K	0.12%	73

Other funds holding ZSAN

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BBVA

Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Markets's ZSAN Position: Q1 2020 in Review

XTX Markets sold out of Zosano Pharma Corporation (ZSAN) in Q1 2020, closing a stake of 313 shares — an estimated $17K sold.

XTX Markets first reported a position in ZSAN in Q4 2019 and held it in 1 quarter. The position peaked at $17K in Q4 2019. 29 funds tracked by Wall St. Rank hold ZSAN as of Q1 2020.

XTX Markets reported no remaining Zosano Pharma Corporation position as of Q1 2020 after selling out during the quarter.
XTX Markets sold 313 Zosano Pharma Corporation shares in Q1 2020, an estimated $17K.
XTX Markets first reported a position in Zosano Pharma Corporation in Q4 2019 and held it in 1 quarter.
XTX Markets's Zosano Pharma Corporation position peaked at $17K in Q4 2019.
29 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2020.

Based on XTX Markets's 13F filing for Q1 2020, filed 20 Apr 2020.